2023-04-01 2024-03-31 false No description of principal activity Capium Accounts Production 1.1 12474195 bus:AbridgedAccounts 2023-04-01 2024-03-31 12474195 bus:Micro-entities 2023-04-01 2024-03-31 12474195 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 12474195 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 12474195 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12474195 2023-04-01 2024-03-31 12474195 2024-03-31 12474195 bus:RegisteredOffice 2023-04-01 2024-03-31 12474195 core:WithinOneYear 2024-03-31 12474195 core:AfterOneYear 2024-03-31 12474195 bus:Director1 2023-04-01 2024-03-31 12474195 bus:Director1 2024-03-31 12474195 bus:Director1 2022-04-01 2023-03-31 12474195 bus:Director2 2023-04-01 2024-03-31 12474195 bus:Director2 2024-03-31 12474195 bus:Director2 2022-04-01 2023-03-31 12474195 bus:Director3 2023-04-01 2024-03-31 12474195 bus:Director3 2024-03-31 12474195 bus:Director3 2022-04-01 2023-03-31 12474195 2022-04-01 12474195 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 12474195 2022-04-01 2023-03-31 12474195 2023-03-31 12474195 core:WithinOneYear 2023-03-31 12474195 core:AfterOneYear 2023-03-31 12474195 bus:EntityAccountantsOrAuditors 2022-04-01 2023-03-31 12474195 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12474195 bus:OrdinaryShareClass1 2024-03-31 12474195 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 12474195 bus:OrdinaryShareClass1 2023-03-31 12474195 core:ComputerEquipment 2023-04-01 2024-03-31 12474195 core:ComputerEquipment 2024-03-31 12474195 core:ComputerEquipment 2023-03-31 12474195 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 12474195 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-03-31 12474195 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 12474195 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 12474195 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 12474195 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 12474195 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 12474195 core:Non-currentFinancialInstruments 2024-03-31 12474195 core:Non-currentFinancialInstruments 2023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12474195
England and Wales

 

 

 

CELIX PHARMA LTD


Abridged Accounts
 


Period of accounts

Start date: 01 April 2023

End date: 31 March 2024
  2024   2023
    £ £   £ £
Fixed assets   6,780     
Current assets 2,684,279      2,351,474   
Prepayments and accrued income 65,420       
Creditors: amount falling due within one year (545,041)     (579,258)  
Net current assets   2,204,658      1,772,216 
Total assets less current liabilities   2,211,438      1,772,216 
Creditors: amount falling due after more than one year       (2,510,001)
Net assets   2,211,438      (737,785)
 

         
Capital and reserves   2,211,438      (737,785)
 
NOTES TO THE ACCOUNTS

General Information
Celix Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 12474195, registration address 12 Constance Street, E16 2DQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 1 (2023 : 0).


For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the board of directors on 07 November 2024 and were signed on its behalf by:


--------------------------------
Subir Kohli
Director
--------------------------------
Shantreddy Channareddy Soogareddy
Director
1